bloated on tirzepatide is FDA-approved for weight management, with clinical trials showing average weight loss of 15–22.5% over 72 weeks. It's a prescription-only therapy, meaning it's not for everyone, and it works by acting How Does Tirzepatide Work? |

Coverage Baseline Previously unavailable under Medicare Part D Only 13 states cover them in Medicaid (KFF HMA survey) 19% of large employers cover GLP-1s for obesity, though 43% of employers with 5,000+ employees offer coverage (KFF 2025 survey) Current Expansion ~50% of CVS Caremark clients now provide coverage for weight loss Medicare GLP-1 Bridge program launches coverage for eligible Medicare Part D patients 7/1/26 This aligns with a recent survey from Business Group on Health that found 67% of the surveyed employers now cover GLP-1s for weight loss (though a reduction is expected for 2027)

Here, Kherkher Garcia's defective drug attorneys discuss how a settlement for Ozempic could help you obtain compensation and justice.

Developed by Novo Nordisk, Ozempic aids in glycemic control and offers the dual benefit of potential weight loss for individuals managing this chronic condition

Available with quick delivery and easy return options

![Figure][1] Graphical Abstract: ### Competing Interest Statement The FR + FMG laboratory receives funding from AstraZeneca, Eli Lilly and LGM for unrelated research and FMG consults for Kallyope (New York)

Shop NEST FDA 510(k) cleared injection pens for chronically administered injectable drugs